Invention Grant
- Patent Title: Antibodies capable of binding to the coagulation factor XIa and uses thereof
-
Application No.: US15691731Application Date: 2017-08-30
-
Publication No.: US10221247B2Publication Date: 2019-03-05
- Inventor: Andreas Wilmen , Julia Straßburger , Frank Dittmer , Michael Strerath , Anja Buchmüller , Joanna Grudzinska-Goebel , Ricarda Finnern , Martina Schäfer , Christoph Gerdes , Hannah Jörißen , Asako Itakura , Philberta Y. Leung , Erik Tucker
- Applicant: BAYER PHARMA AKTIENGESELLSCHAFT
- Applicant Address: DE Berlin
- Assignee: BAYER PHARMA AKTIENGESELLSCHAFT
- Current Assignee: BAYER PHARMA AKTIENGESELLSCHAFT
- Current Assignee Address: DE Berlin
- Agency: Nixon & Vanderhye P.C.
- Priority: EP12167438 20120510; EP12181697 20120824; EP13150361 20130107
- Main IPC: C07K16/36
- IPC: C07K16/36 ; A61K39/00
Abstract:
The present invention relates to antibodies capable of binding to the coagulation Factor XI and/or its activated form factor XIa and methods of use thereof, particularly methods of use as agents inhibiting platelet aggregation and by this inhibits thrombus formation.
Public/Granted literature
- US20180112009A1 ANTIBODIES CAPABLE OF BINDING TO THE COAGULATION FACTOR XIA AND USES THEREOF Public/Granted day:2018-04-26
Information query
